299 related articles for article (PubMed ID: 10924796)
1. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Pushko P; Bray M; Ludwig GV; Parker M; Schmaljohn A; Sanchez A; Jahrling PB; Smith JF
Vaccine; 2000 Aug; 19(1):142-53. PubMed ID: 10924796
[TBL] [Abstract][Full Text] [Related]
2. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
3. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.
Hevey M; Negley D; Pushko P; Smith J; Schmaljohn A
Virology; 1998 Nov; 251(1):28-37. PubMed ID: 9813200
[TBL] [Abstract][Full Text] [Related]
4. Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
[TBL] [Abstract][Full Text] [Related]
5. Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.
Herbert AS; Kuehne AI; Barth JF; Ortiz RA; Nichols DK; Zak SE; Stonier SW; Muhammad MA; Bakken RR; Prugar LI; Olinger GG; Groebner JL; Lee JS; Pratt WD; Custer M; Kamrud KI; Smith JF; Hart MK; Dye JM
J Virol; 2013 May; 87(9):4952-64. PubMed ID: 23408633
[TBL] [Abstract][Full Text] [Related]
6. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
[TBL] [Abstract][Full Text] [Related]
7. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
[TBL] [Abstract][Full Text] [Related]
8. Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine.
Fluet ME; Whitmore AC; Moshkoff DA; Fu K; Tang Y; Collier ML; West A; Moore DT; Swanstrom R; Johnston RE; Davis NL
Virology; 2008 Jan; 370(1):22-32. PubMed ID: 17904185
[TBL] [Abstract][Full Text] [Related]
9. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
[TBL] [Abstract][Full Text] [Related]
10. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.
Agnihothram S; Menachery VD; Yount BL; Lindesmith LC; Scobey T; Whitmore A; Schäfer A; Heise MT; Baric RS
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540599
[TBL] [Abstract][Full Text] [Related]
11. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.
Velders MP; McElhiney S; Cassetti MC; Eiben GL; Higgins T; Kovacs GR; Elmishad AG; Kast WM; Smith LR
Cancer Res; 2001 Nov; 61(21):7861-7. PubMed ID: 11691804
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.
Kamrud KI; Alterson KD; Andrews C; Copp LO; Lewis WC; Hubby B; Patel D; Rayner JO; Talarico T; Smith JF
PLoS One; 2008 Jul; 3(7):e2709. PubMed ID: 18628938
[TBL] [Abstract][Full Text] [Related]
13. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.
Wilson JA; Hart MK
J Virol; 2001 Mar; 75(6):2660-4. PubMed ID: 11222689
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.
Gipson CL; Davis NL; Johnston RE; de Silva AM
Vaccine; 2003 Sep; 21(25-26):3875-84. PubMed ID: 12922122
[TBL] [Abstract][Full Text] [Related]
15. An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.
White LJ; Parsons MM; Whitmore AC; Williams BM; de Silva A; Johnston RE
J Virol; 2007 Oct; 81(19):10329-39. PubMed ID: 17652394
[TBL] [Abstract][Full Text] [Related]
16. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.
Olinger GG; Bailey MA; Dye JM; Bakken R; Kuehne A; Kondig J; Wilson J; Hogan RJ; Hart MK
J Virol; 2005 Nov; 79(22):14189-96. PubMed ID: 16254354
[TBL] [Abstract][Full Text] [Related]
17. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
18. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.
Lee JS; Pushko P; Parker MD; Dertzbaugh MT; Smith LA; Smith JF
Infect Immun; 2001 Sep; 69(9):5709-15. PubMed ID: 11500447
[TBL] [Abstract][Full Text] [Related]
19. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
20. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
